(Q37856731)

24 August 2017

Leprosy therapy, past and present: can we hope to eliminate it? (English)

1 reference

24 August 2017

0 references

P V S Prasad

1

1 reference

24 August 2017

P K Kaviarasan

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Indian Journal of Dermatology

24 August 2017

1 reference

24 August 2017

55

1 reference

24 August 2017

4

1 reference

24 August 2017

316-324

1 reference

The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.

24 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

The impact of leprosy control on the transmission of M. leprae: is elimination being attained?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Advances in the treatment of reactions in leprosy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

The role of thalidomide in the management of erythema nodosum leprosum.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

The continuing challenges of leprosy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

'Final push of leprosy' in India: What is being pushed?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Multidrug resistant Mycobacterium leprae from patients with leprosy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Patient contact is the major determinant in incident leprosy: implications for future control.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

The principles of disease elimination and eradication.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Molecular basis of rifampin resistance in Mycobacterium leprae

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Trends in leprosy case detection worldwide since 1985.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Drug compliance in the treatment of leprosy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Leprosy: the epidemiology of a slow bacterium

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Needed research in chemotherapy of leprosy related to the individual patient.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Trends in leprosy case detection rates.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

We need to know what is happening to the incidence of leprosy.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Reversal reactions in lepromatous leprosy following transfer factor therapy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Report of the ninth meeting of the WHO Technical Advisory Group on Leprosy Control: Cairo, Egypt, 6-7 March 2008.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Vaccination against leprosy--the view from 1996.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3051288

Long-term follow up of lepromatous leprosy patients receiving intralesional recombinant gamma-interferon

1 September 2018

1 reference

12 December 2020

Contact with armadillos increases the risk of leprosy in Brazil: A case control study

1 reference

12 December 2020

Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline

1 reference

12 December 2020

Is there a role for a vaccine in leprosy control?

1 reference

12 December 2020

Clofazimine and dapsone compliance in leprosy

1 reference

12 December 2020

Leprosy research declines, but most of the basic questions remain unanswered

1 reference

12 December 2020

Leprosy by the year 2000--what is being eliminated?

1 reference

12 December 2020

WHO Expert Committee on Leprosy

1 reference

12 December 2020

Current World Health Organization-sponsored studies in the chemotherapy of leprosy

1 reference

12 December 2020

Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years

1 reference

12 December 2020

Leprosy's global statistics--still room for improvement

1 reference

12 December 2020

New emerging drug regimens for leprosy

1 reference

12 December 2020

Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group

1 reference

12 December 2020

Global leprosy situation, 2007

1 reference

12 December 2020

Report of the International Leprosy Association Technical Foum. 25-28 February 2002. Paris, France

1 reference

12 December 2020

The final push strategy to eliminate leprosy as a public health problem: questions and answers

1 reference

12 December 2020

Methods for the classification of leprosy for treatment purposes

1 reference

12 December 2020

Pharmacokinetics and drug interactions of newer anti -leprosy drugs

1 reference

12 December 2020

Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions

1 reference

12 December 2020

WHO Expert Committee on Leprosy

1 reference

12 December 2020

Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy

1 reference

12 December 2020

Global leprosy situation, beginning of 2008

1 reference

12 December 2020

Classifying leprosy patients--searching for the perfect solution?

1 reference

12 December 2020

Identifiers

DOI

10.4103/0019-5154.74528

1 reference

24 August 2017

1 reference

24 August 2017

PubMed publication ID

21430881

1 reference